Cargando…

Delineating the autistic phenotype in children with neurofibromatosis type 1

BACKGROUND: Existing research has demonstrated elevated autistic behaviours in children with neurofibromatosis type 1 (NF1), but the autistic phenotype and its relationship to other neurodevelopmental manifestations of NF1 remains unclear. To address this gap, we performed detailed characterisation...

Descripción completa

Detalles Bibliográficos
Autores principales: Chisholm, Anita K., Haebich, Kristina M., Pride, Natalie A., Walsh, Karin S., Lami, Francesca, Ure, Alex, Maloof, Tiba, Brignell, Amanda, Rouel, Melissa, Granader, Yael, Maier, Alice, Barton, Belinda, Darke, Hayley, Dabscheck, Gabriel, Anderson, Vicki A., Williams, Katrina, North, Kathryn N., Payne, Jonathan M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8729013/
https://www.ncbi.nlm.nih.gov/pubmed/34983638
http://dx.doi.org/10.1186/s13229-021-00481-3
_version_ 1784626850028322816
author Chisholm, Anita K.
Haebich, Kristina M.
Pride, Natalie A.
Walsh, Karin S.
Lami, Francesca
Ure, Alex
Maloof, Tiba
Brignell, Amanda
Rouel, Melissa
Granader, Yael
Maier, Alice
Barton, Belinda
Darke, Hayley
Dabscheck, Gabriel
Anderson, Vicki A.
Williams, Katrina
North, Kathryn N.
Payne, Jonathan M.
author_facet Chisholm, Anita K.
Haebich, Kristina M.
Pride, Natalie A.
Walsh, Karin S.
Lami, Francesca
Ure, Alex
Maloof, Tiba
Brignell, Amanda
Rouel, Melissa
Granader, Yael
Maier, Alice
Barton, Belinda
Darke, Hayley
Dabscheck, Gabriel
Anderson, Vicki A.
Williams, Katrina
North, Kathryn N.
Payne, Jonathan M.
author_sort Chisholm, Anita K.
collection PubMed
description BACKGROUND: Existing research has demonstrated elevated autistic behaviours in children with neurofibromatosis type 1 (NF1), but the autistic phenotype and its relationship to other neurodevelopmental manifestations of NF1 remains unclear. To address this gap, we performed detailed characterisation of autistic behaviours in children with NF1 and investigated their association with other common NF1 child characteristics. METHODS: Participants were drawn from a larger cross-sectional study examining autism in children with NF1. The population analysed in this study scored above threshold on the Social Responsiveness Scale-Second Edition (T-score ≥ 60; 51% larger cohort) and completed the Autism Diagnostic Interview-Revised (ADI-R) and/or the Autism Diagnostic Observation Schedule-Second Edition (ADOS-2). All participants underwent evaluation of their intellectual function, and behavioural data were collected via parent questionnaires. RESULTS: The study cohort comprised 68 children (3–15 years). Sixty-three per cent met the ADOS-2 ‘autism spectrum’ cut-off, and 34% exceeded the more stringent threshold for ‘autistic disorder’ on the ADI-R. Social communication symptoms were common and wide-ranging, while restricted and repetitive behaviours (RRBs) were most commonly characterised by ‘insistence on sameness’ (IS) behaviours such as circumscribed interests and difficulties with minor changes. Autistic behaviours were weakly correlated with hyperactive/impulsive attention deficit hyperactivity disorder (ADHD) symptoms but not with inattentive ADHD or other behavioural characteristics. Language and verbal IQ were weakly related to social communication behaviours but not to RRBs. LIMITATIONS: Lack of genetic validation of NF1, no clinical diagnosis of autism, and a retrospective assessment of autistic behaviours in early childhood. CONCLUSIONS: Findings provide strong support for elevated autistic behaviours in children with NF1. While these behaviours were relatively independent of other NF1 comorbidities, the importance of taking broader child characteristics into consideration when interpreting data from autism-specific measures in this population is highlighted. Social communication deficits appear similar to those observed in idiopathic autism and are coupled with a unique RRB profile comprising prominent IS behaviours. This autistic phenotype and its relationship to common NF1 comorbidities such as anxiety and executive dysfunction will be important to examine in future research. Current findings have important implications for the early identification of autism in NF1 and clinical management. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13229-021-00481-3.
format Online
Article
Text
id pubmed-8729013
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-87290132022-01-06 Delineating the autistic phenotype in children with neurofibromatosis type 1 Chisholm, Anita K. Haebich, Kristina M. Pride, Natalie A. Walsh, Karin S. Lami, Francesca Ure, Alex Maloof, Tiba Brignell, Amanda Rouel, Melissa Granader, Yael Maier, Alice Barton, Belinda Darke, Hayley Dabscheck, Gabriel Anderson, Vicki A. Williams, Katrina North, Kathryn N. Payne, Jonathan M. Mol Autism Research BACKGROUND: Existing research has demonstrated elevated autistic behaviours in children with neurofibromatosis type 1 (NF1), but the autistic phenotype and its relationship to other neurodevelopmental manifestations of NF1 remains unclear. To address this gap, we performed detailed characterisation of autistic behaviours in children with NF1 and investigated their association with other common NF1 child characteristics. METHODS: Participants were drawn from a larger cross-sectional study examining autism in children with NF1. The population analysed in this study scored above threshold on the Social Responsiveness Scale-Second Edition (T-score ≥ 60; 51% larger cohort) and completed the Autism Diagnostic Interview-Revised (ADI-R) and/or the Autism Diagnostic Observation Schedule-Second Edition (ADOS-2). All participants underwent evaluation of their intellectual function, and behavioural data were collected via parent questionnaires. RESULTS: The study cohort comprised 68 children (3–15 years). Sixty-three per cent met the ADOS-2 ‘autism spectrum’ cut-off, and 34% exceeded the more stringent threshold for ‘autistic disorder’ on the ADI-R. Social communication symptoms were common and wide-ranging, while restricted and repetitive behaviours (RRBs) were most commonly characterised by ‘insistence on sameness’ (IS) behaviours such as circumscribed interests and difficulties with minor changes. Autistic behaviours were weakly correlated with hyperactive/impulsive attention deficit hyperactivity disorder (ADHD) symptoms but not with inattentive ADHD or other behavioural characteristics. Language and verbal IQ were weakly related to social communication behaviours but not to RRBs. LIMITATIONS: Lack of genetic validation of NF1, no clinical diagnosis of autism, and a retrospective assessment of autistic behaviours in early childhood. CONCLUSIONS: Findings provide strong support for elevated autistic behaviours in children with NF1. While these behaviours were relatively independent of other NF1 comorbidities, the importance of taking broader child characteristics into consideration when interpreting data from autism-specific measures in this population is highlighted. Social communication deficits appear similar to those observed in idiopathic autism and are coupled with a unique RRB profile comprising prominent IS behaviours. This autistic phenotype and its relationship to common NF1 comorbidities such as anxiety and executive dysfunction will be important to examine in future research. Current findings have important implications for the early identification of autism in NF1 and clinical management. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13229-021-00481-3. BioMed Central 2022-01-04 /pmc/articles/PMC8729013/ /pubmed/34983638 http://dx.doi.org/10.1186/s13229-021-00481-3 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Chisholm, Anita K.
Haebich, Kristina M.
Pride, Natalie A.
Walsh, Karin S.
Lami, Francesca
Ure, Alex
Maloof, Tiba
Brignell, Amanda
Rouel, Melissa
Granader, Yael
Maier, Alice
Barton, Belinda
Darke, Hayley
Dabscheck, Gabriel
Anderson, Vicki A.
Williams, Katrina
North, Kathryn N.
Payne, Jonathan M.
Delineating the autistic phenotype in children with neurofibromatosis type 1
title Delineating the autistic phenotype in children with neurofibromatosis type 1
title_full Delineating the autistic phenotype in children with neurofibromatosis type 1
title_fullStr Delineating the autistic phenotype in children with neurofibromatosis type 1
title_full_unstemmed Delineating the autistic phenotype in children with neurofibromatosis type 1
title_short Delineating the autistic phenotype in children with neurofibromatosis type 1
title_sort delineating the autistic phenotype in children with neurofibromatosis type 1
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8729013/
https://www.ncbi.nlm.nih.gov/pubmed/34983638
http://dx.doi.org/10.1186/s13229-021-00481-3
work_keys_str_mv AT chisholmanitak delineatingtheautisticphenotypeinchildrenwithneurofibromatosistype1
AT haebichkristinam delineatingtheautisticphenotypeinchildrenwithneurofibromatosistype1
AT pridenataliea delineatingtheautisticphenotypeinchildrenwithneurofibromatosistype1
AT walshkarins delineatingtheautisticphenotypeinchildrenwithneurofibromatosistype1
AT lamifrancesca delineatingtheautisticphenotypeinchildrenwithneurofibromatosistype1
AT urealex delineatingtheautisticphenotypeinchildrenwithneurofibromatosistype1
AT malooftiba delineatingtheautisticphenotypeinchildrenwithneurofibromatosistype1
AT brignellamanda delineatingtheautisticphenotypeinchildrenwithneurofibromatosistype1
AT rouelmelissa delineatingtheautisticphenotypeinchildrenwithneurofibromatosistype1
AT granaderyael delineatingtheautisticphenotypeinchildrenwithneurofibromatosistype1
AT maieralice delineatingtheautisticphenotypeinchildrenwithneurofibromatosistype1
AT bartonbelinda delineatingtheautisticphenotypeinchildrenwithneurofibromatosistype1
AT darkehayley delineatingtheautisticphenotypeinchildrenwithneurofibromatosistype1
AT dabscheckgabriel delineatingtheautisticphenotypeinchildrenwithneurofibromatosistype1
AT andersonvickia delineatingtheautisticphenotypeinchildrenwithneurofibromatosistype1
AT williamskatrina delineatingtheautisticphenotypeinchildrenwithneurofibromatosistype1
AT northkathrynn delineatingtheautisticphenotypeinchildrenwithneurofibromatosistype1
AT paynejonathanm delineatingtheautisticphenotypeinchildrenwithneurofibromatosistype1